QR Code (код быстрого отклика)

Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021

The aim of this review is to update the current status of allogeneic hemopoietic stem cell transplants (HSCT) for patients with myelofibrosis (MF). We have first summarized the issue of an indication for allogeneic HSCT, discussing several prognostic scoring systems, developed to predict the outcome...

Полное описание

Сохранить в:
Главные авторы: Andrea Bacigalupo, Idanna Innocenti, Elena Rossi, Federica Sora, Eugenio Galli, Francesco Autore, Elisabetta Metafuni, Patrizia Chiusolo, Sabrina Giammarco, Luca Laurenti, Giulia Benintende, Simona Sica, Valerio De Stefano
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2021-05-01
Серии:Frontiers in Immunology
Предметы:
myelofibrosis
allogeneic transplantation
busulfan
thiotepa
fludarabine chimerism
splenectomy
Online-ссылка:https://www.frontiersin.org/articles/10.3389/fimmu.2021.637512/full
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы